How Will IQVIA One Home for Sites™ Simplify Clinical Trial Technology? Questions And Answers For Sponsors, Partners, And Sites

Sites are frequently overwhelmed with the sheer number of technologies they must work with to conduct a clinical trial. This challenge can delay studies or even halt them prematurely, costing the pharmaceutical sponsors valuable time and resources. To solve this problem, IQVIA Technologies built One Home for Sites™, an aggregation platform that connects and communicates the key systems and tasks a site needs to perform across all the clinical trials it conducts.

IQVIA recently hosted a webinar introducing this emerging platform to sponsors, sites, and partners. Presenters Lesley Freese, senior product manager of One Home for Sites, Robert Osterhaus, director of Global Technology Partners, and KK Rumrill, senior director and general manager of Site and Planning Suites for IQVIA Technologies, led a lively question and answer session that covered key topics such as:

• How can technology vendors become part of One Home for Sites?
• Will One Home for Sites replace existing technology, or enhance it?
• Does One Home for Sites work for all types of studies?
• Will sponsors be able to include other service providers besides IQVIA in One Home?